Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.645 USD | -2.40% | -7.84% | -21.28% |
02/05 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
01/05 | Malin Corp investee signs agreement with Astellas Pharma | AN |
Sales 2024 * | 52.92M 4.42B | Sales 2025 * | 27.5M 2.3B | Capitalization | 256M 21.4B |
---|---|---|---|---|---|
Net income 2024 * | -179M -14.94B | Net income 2025 * | -225M -18.79B | EV / Sales 2024 * | 4.84 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.32 x |
P/E ratio 2024 * |
-1.57
x | P/E ratio 2025 * |
-1.49
x | Employees | 330 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.23% |
1 day | -2.40% | ||
1 week | -7.84% | ||
Current month | +9.30% | ||
1 month | -5.20% | ||
3 months | -26.53% | ||
6 months | +20.78% | ||
Current year | -21.28% |
Managers | Title | Age | Since |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/23/01 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01/15/01 |
Mark Gergen
CHM | Chairman | 61 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01/19/01 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23/21/23 |
Mark Gergen
CHM | Chairman | 61 | 01/18/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.87% | 2 M€ | -25.75% | ||
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 2.645 | -2.40% | 368,911 |
09/24/09 | 2.71 | 0.00% | 417,831 |
08/24/08 | 2.71 | -7.19% | 359,616 |
07/24/07 | 2.92 | +3.18% | 385,765 |
06/24/06 | 2.83 | -1.39% | 546,658 |
Delayed Quote Nasdaq, May 11, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.28% | 256M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PSTX Stock